This page was created for students and residents assigned to Dr. Fudin.  For students assigned to Dr. Fudin, you should receive information from your college well in advance of the first day.  There are several items that require completion prior to starting rotation, including certain necessary documents and fingerprinting.  If these are not completed prior to rotation, you will not be permitted to start.   Parking has not been made available on the VA campus for local ACPHS students, although there is ample parking on New Scotland Avenue in front of the VA.  Arrangements are in process for out-of-town students including those from WNEU, SUNY Buffalo, and others. The following readings are made available for Pharmacy Residents & Students on rotation with Dr. Fudin.  Additional pertinent REQUIRED readings will be assigned while on rotation. Helpful templates and files will be provided on first rotation day.  Also see student pain assessment sheet HERE.

To access the list that appears below on a PDF Document with hyperlinks, please contact Dr. Jeffrey Fudin for pass code to encrypted document. Also, see HERE for a summary of neuropathic pain physiology, pathology, and commonly prescribed medications for treatment.

Articles to be read prior to commencing rotation:
1. Brooks A, Kominek C, Pham T, Fudin J. Exploring the Use of Chronic Opioid Therapy for Chronic Pain: When, How, and for Whom? Med Clin N Am 100 (2016) 81-102.
2. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Duener R. Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy. NEJM. Vol. 326, No.19. May 7, 1992. pp. 1250-1256.
3. Zorn KE, Fudin J. Treatment of Neuropathic Pain: the Role of Unique Opioid Agents. Practical Pain Management. 2011 May; 11 (4): 26-33.

Articles to be read by the end of the first week on rotation:
1. Boglish P, Fudin J. Is tapentadol a glorified tramadol? Practical Pain Management. Jan/Feb 2016 18-20.
2. Fudin J, Raouf M, Wegrzyn WL. Pharmacological Considerations Regarding Equianalgesic Dosing. A White Paper from the Academy of Integrative Pain Management. September 2017.
3. Fudin J, Marcoux MD, Fudin JA. Mathematical Model For Methadone Conversion Examined. Practical Pain Management. Sept. 2012. 46-51.
4. Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV. The clinical analgesic efficacy of buprenorphine. Journal of clinical pharmacy and therapeutics. 2014 Dec 1;39(6):577-83.
5. Raouf M, Fudin J. A Review of Skeletal Muscle Relaxants For Pain Management. Practical Pain Management. 2016 June; 42-60.
6. Zelder B et al. Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans’ Health Administration Patients. Pain Medicine 2015.

Articles that will enhance your knowledge and insight, and make you think. These are highly encouraged and will be provided upon request:
1. Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication Management in the Elderly: Unique and Underutilized Treatment options. Clinical Therapeutics. 2013 Nov. Vol. 34, Pages 1669-1689.
2. Fudin J, Fontenelle DV, Fudin HR, Carlyn C, Ashley CC, Hinden DA. Potential P-glycoprotein Pharmacokinetic Interaction of Telaprevir with Morphine or Methadone. Journal of Pain and Palliative Care Pharmacotherapy. August 2013, Vol. 27, No. 3, Pages 261-267.
3. Fudin J, Fontenelle DV, Payne A. Rifampin Reduces Oral Morphine Absorption; A Case of Transdermal Buprenorphine Selection Based on Morphine Pharmacokinetics. Journal of Pain & Palliative Care Pharmacotherapy. 2012;26:362–367.
4. Shaw K, Fudin J. Evaluation and Comparison of Online Equianalgesic Opioid Dose Conversion Calculators. Practical Pain Management. 2013 August; 13(7):61-66.

Other articles to read for additional insight:
Drug-specific:
1. Gudin J, Fudin J, Nalamachu S. Levorphanol Use: Past, Present and Future. Postgraduate Medicine. 03 December 2015.
2. Pham TC, Fudin J, Raffa RB. Is Levorphanol a Better Option Than Methadone? Pain Medicine. 2015 September; 16(9):1673-1679.
3. Marcucci C, Fudin J, Thomas P, et al. A new pattern of buprenorphine misuse may complicate perioperative pain control. [Case Reports, Letter]. Anesth Analg 2009 Jun; 108(6):1996-7.

Urine Drug Screening:
1. Hammett-Stabler CA, Webster LR. A Clinical Guide to Urine Drug Testing. An educational activity designed for primary care physicians, family physicians, and pain physicians.
2. Leavitt SB, Reisfield GM. Introducing “Understanding UDT in Pain Care”. Blog post on Paintopics.org. August 27, 2012.
3. Moeller KE, Lee KC, Kissack JC. Urine Drug Screening:Practical Guide for Clinicians. Mayo Clin roc. January 2008;83(1):66-76

Pharmacodynamics/kinetics/genomics:
1. Flockhart DA, Lu WJ. Pharmacogenetics: Personalizing Pain Medicine. Supplement in Practical Pain Management. 2014 September; 14(8):49-57.
2. Owusu-Obeng A, Weitzel KW,4 Hatton RC, Staley BJ, Ashton J, Cooper-Dehoff RM, Johnson JA. Emerging Roles for Pharmacists in Clinical Implementation of Pharmacogenomics. Pharmacotherapy. 2014. 34(10): 1102-12.
3. Vuilleumier PH, Stamer UM, Landau R. Pharmacogenomic considerations in opioid analgesia. Pharmacogenomics and Personalized Medicine. 2012:5 73–87.

Pain Management with Comorbidities/Concurrent Therapies:
1. Crana S, Fudin J. Drug Interactions Among HIV Patients Receiving Concurrent Antiretroviral and Pain Therapy. Practical Pain Management 2011 October:105-118,120-124.
2. Dedhia JD, Bone ME. Pain and fibromyalgia. Continuing Education in Anaesthesia, Critical Care & Pain j Volume 9 Number 5 2009. 162-166.
3. Fudin J, Levasseur DJ, Passik SD, Kirsh KL, Coleman J. Chronic Pain Management with Opioids in Patients with Past or Current Substance Abuse Problems. Journal of Pharmacy Practice. 2003, 16;4:291-308.
4. Sasu-Tenkoramaa J, Fudin J. Drug Interactions in Cancer Patients Requiring Concomitant Chemotherapy and Analgesics. Practical Pain Management. 2013 May; 13 (4):50-64.
5. Sasu-Tenkoramaa J, Fudin J. Neuropathy in the Cancer Patient: Causes and Cures. Practical Pain Management. 2013 April; 13(3):53-67.

General Treatment/Guideline/OTHER:
1. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P,6 Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O’Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C. FOR THE AMERICAN PAIN SOCIETY–AMERICAN ACADEMY OF PAIN MEDICINE OPIOIDS GUIDELINES PANEL Opioid Treatment Guidelines, Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain, Vol 10, No. 2 (February), 2009: pp 113-130.
2. Fudin J. Update on Risk Evaluation and Mitigation Strategies (REMS) associated with long-acting opioids. CE program of the University of Connecticut School of Pharmacy and Drug Topics. Drug topics. 2011 October:45-58.
3. Fudin J. Opioid pain management: Balancing risks and benefits. CE program of the University of Connecticut School of Pharmacy and Drug Topics. Drug topics. 2011 September:46-58.
4. Pizzi LT, Toner R, Foley K, Thomson E, Chow W, Kim M, Couto J, Royo M, and Viscusi E. Relationship Between Potential Opioid-Related Adverse Effects and Hospital Length of Stay in Patients Receiving Opioids After Orthopedic Surgery. Pharmacotherapy 2012;32(6):502–514.
5. Schafer AI. Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis. J Clin Pharmacol 1995 35: 209-219.
6. Younan M, Atkinson TJ, Fudin J. A Practical Approach to Discontinuing NSAID Therapy Prior to a Procedure. Practical Pain Management. 2013 Nov/Dec; 13(10):45-51.

IMPORTANT REFERENCE FILES: See QUICK REFERENCES page on this site. When seeing patients, all students/residents should have access to Urintel to help decipher urine drug screens.  Please bring a hard copy of opioid chemistry, NSAID chemical classes, antidepressant chemical classes, and opioid serum predictabilities which also lists opioid metabolites to clinics.